PROCEPT BioRobotics Corporation

BMV:PRCT * Stock Report

Market Cap: Mex$64.4b

PROCEPT BioRobotics Management

Management criteria checks 2/4

PROCEPT BioRobotics' CEO is Reza Zadno, appointed in Feb 2020, has a tenure of 5.08 years. total yearly compensation is $6.09M, comprised of 10.1% salary and 89.9% bonuses, including company stock and options. directly owns 0.096% of the company’s shares, worth MX$61.66M. The average tenure of the management team and the board of directors is 5.1 years and 3.8 years respectively.

Key information

Reza Zadno

Chief executive officer

US$6.1m

Total compensation

CEO salary percentage10.1%
CEO tenure5.1yrs
CEO ownership0.1%
Management average tenure5.1yrs
Board average tenure3.8yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Reza Zadno's remuneration changed compared to PROCEPT BioRobotics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

-US$91m

Sep 30 2024n/an/a

-US$100m

Jun 30 2024n/an/a

-US$104m

Mar 31 2024n/an/a

-US$103m

Dec 31 2023US$6mUS$613k

-US$106m

Sep 30 2023n/an/a

-US$107m

Jun 30 2023n/an/a

-US$105m

Mar 31 2023n/an/a

-US$98m

Dec 31 2022US$4mUS$575k

-US$87m

Sep 30 2022n/an/a

-US$77m

Jun 30 2022n/an/a

-US$69m

Mar 31 2022n/an/a

-US$64m

Dec 31 2021US$1mUS$490k

-US$60m

Sep 30 2021n/an/a

-US$57m

Jun 30 2021n/an/a

-US$55m

Mar 31 2021n/an/a

-US$53m

Dec 31 2020US$4mUS$435k

-US$53m

Compensation vs Market: Reza's total compensation ($USD6.09M) is above average for companies of similar size in the MX market ($USD1.23M).

Compensation vs Earnings: Reza's compensation has increased whilst the company is unprofitable.

CEO

Reza Zadno (69 yo)

5.1yrs

Tenure

US$6,088,813

Compensation

Dr. Reza Zadno, Ph D., has been the President, Chief Executive Officer and Director at Procept Biorobotics Corporation since February 2020. Dr. Zadno served as the Chief Executive Officer at Avedro, Inc. f...

Leadership Team

NamePositionTenureCompensationOwnership
Reza Zadno
President5.1yrsUS$6.09m0.096%
MX$ 61.7m
Kevin Waters
Executive VP & CFO6.4yrsUS$2.67m0.12%
MX$ 78.3m
Alaleh Nouri
EVP, Chief Legal Officer & Corporate Secretary6.7yrsUS$2.19m0.043%
MX$ 27.5m
Hisham Shiblaq
Executive VP & Chief Commercial Officer6yrsUS$2.63m0.033%
MX$ 21.2m
Mohan Sancheti
Senior Vice President of Operationsno datano datano data
Barry Templin
Executive VP of Technology & Clinical Development1.3yrsno datano data
Matthew Bacso
Vice President of Investor Relationsno datano datano data
Stacey Porter
Chief People Officer1.2yrsno datano data
Bijesh Chandran
Senior Vice President of Regulatory Affairs & Quality Assurance3.2yrsno datano data

5.1yrs

Average Tenure

48yo

Average Age

Experienced Management: PRCT *'s management team is seasoned and experienced (5.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Reza Zadno
President5.1yrsUS$6.09m0.096%
MX$ 61.7m
Thomas Prescott
Chairperson of the Boardless than a yearno datano data
Frederic Moll
Independent Director13.6yrsUS$277.64k1.53%
MX$ 987.5m
Taylor Harris
Independent Director4.3yrsUS$254.92k0.24%
MX$ 154.3m
Larry Wood
Independent Directorless than a yearno datano data
Elisabeth Sandoval-Little
Independent Director3.4yrsUS$242.16k0.015%
MX$ 9.4m
Mary Garrett
Independent Director3.3yrsUS$244.92k0.017%
MX$ 10.8m
Antal Desai
Independent Director9.8yrsUS$247.42k0.31%
MX$ 199.6m
Amy Dodrill
Independent Director3.8yrsUS$252.42k0.0086%
MX$ 5.5m

3.8yrs

Average Tenure

62yo

Average Age

Experienced Board: PRCT *'s board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/24 22:52
End of Day Share Price 2025/03/13 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PROCEPT BioRobotics Corporation is covered by 17 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Craig BijouBofA Global Research
Neil ChatterjiB. Riley Securities, Inc.
Michael GormanBTIG